STSS Sharps Technology, Inc.
Healthcare$1.82+0.00%OpenMarket Cap: $77.2M
As of 2026-05-26
Valuation
P/E (TTM)
—
PEG
—
P/B
0.73
P/S
193.00
EV/EBITDA
-0.24
DCF Value
$0.41
FCF Yield
-264.9%
Div Yield
0.0%
Margins & Returns
Gross Margin
-106.6%
Operating Margin
-3990.1%
Net Margin
-93391.3%
ROE
-166.4%
ROA
-204.8%
ROIC
-8.9%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $192.8K | -5.1% | $-4.6M | $-86.2M | $— | — |
| Q4 null | $-102.2K | -1749.5% | $102.4M | $-182.7M | $— | — |
| FY null | $204.1K | -202.5% | $-13.3M | $-282.5M | $— | — |
| Q3 null | $83.6K | -1398.7% | $-110.6M | $-105.3M | $— | — |
| Q2 null | $222.7K | -463.4% | $-3.0M | $3.6M | $— | — |
| Q1 null | $0.00 | NaN% | $-2.0M | $1.9M | $— | — |
| Q4 null | $0.00 | -Infinity% | $-2.1M | $-4.5M | $— | — |
| FY null | $0.00 | -Infinity% | $-7.9M | $-9.3M | $— | — |
| Q3 null | $0.00 | -Infinity% | $-2.0M | $-1.7M | $— | — |
| Q2 null | $0.00 | -Infinity% | $-1.9M | $-2.1M | $— | — |
| Q1 null | $0.00 | -Infinity% | $-1.8M | $-982.4K | $— | — |
| Q4 2023 | $0.00 | -Infinity% | $-2.9M | $-3.1M | $-1,340.20 | — |